111 related articles for article (PubMed ID: 1477075)
1. Induction of circulating phospholipase A2 activity by intravenous infusion of endotoxin in patients with neoplasia.
Pruzanski W; Mackensen A; Engelhardt R; Stefanski E; Vadas P
J Immunother (1991); 1992 Nov; 12(4):242-6. PubMed ID: 1477075
[TBL] [Abstract][Full Text] [Related]
2. Hyperphospholipasemia A2 in human volunteers challenged with intravenous endotoxin.
Pruzanski W; Wilmore DW; Suffredini A; Martich GD; Hoffman AG; Browning JL; Stefanski E; Sternby B; Vadas P
Inflammation; 1992 Oct; 16(5):561-70. PubMed ID: 1428127
[TBL] [Abstract][Full Text] [Related]
3. Secretory non-pancreatic phopholipase A2 in severe sepsis: relation to endotoxin, cytokines and thromboxane B2.
Guidet B; Piot O; Masliah J; Barakett V; Maury E; Bereziat G; Offenstadt G
Infection; 1996; 24(2):103-8. PubMed ID: 8740100
[TBL] [Abstract][Full Text] [Related]
4. Plasma levels of type II phospholipase A2 and cytokines in patients with sepsis.
Endo S; Inada K; Nakae H; Takakuwa T; Yamada Y; Suzuki T; Taniguchi S; Yoshida M; Ogawa M; Teraoka H
Res Commun Mol Pathol Pharmacol; 1995 Dec; 90(3):413-21. PubMed ID: 8746487
[TBL] [Abstract][Full Text] [Related]
5. Involvement of circulating phospholipase A2 in the pathogenesis of the hemodynamic changes in endotoxin shock.
Vadas P; Hay JB
Can J Physiol Pharmacol; 1983 Jun; 61(6):561-6. PubMed ID: 6883208
[TBL] [Abstract][Full Text] [Related]
6. Are events after endotoxemia related to circulating phospholipase A2?
Santos AA; Browning JL; Scheltinga MR; Lynch EA; Brown EF; Lawton P; Chambers E; Dougas I; Benjamin CD; Dinarello CA
Ann Surg; 1994 Feb; 219(2):183-92. PubMed ID: 8129489
[TBL] [Abstract][Full Text] [Related]
7. Extracellular phospholipase A2 secretion is a common effector pathway of interleukin-1 and tumour necrosis factor action.
Vadas P; Pruzanski W; Stefanski E; Ellies LG; Aubin JE; Sos A; Melcher A
Immunol Lett; 1991 Jun; 28(3):187-93. PubMed ID: 1885215
[TBL] [Abstract][Full Text] [Related]
8. Endotoxin stimulates the expression of group II PLA2 in rat lung in vivo and in isolated perfused lungs.
Ljungman AG; Tagesson C; Lindahl M
Am J Physiol; 1996 May; 270(5 Pt 1):L752-60. PubMed ID: 8967509
[TBL] [Abstract][Full Text] [Related]
9. Phospholipase A2 is a circulating mediator in typhoid fever.
Keuter M; Dharmana E; Kullberg BJ; Schalkwijk C; Gasem MH; Seuren L; Djokomoeljanto R; Dolmans WM; van den Bosch H; van der Meer JW
J Infect Dis; 1995 Jul; 172(1):305-8. PubMed ID: 7797937
[TBL] [Abstract][Full Text] [Related]
10. Endotoxin, interleukin-6 and phospholipase-A2 as markers of sepsis in patients with hematological malignancies.
Rintala E; Pulkki K; Mertsola J; Nevalainen T; Nikoskelainen J
Scand J Infect Dis; 1995; 27(1):39-43. PubMed ID: 7784812
[TBL] [Abstract][Full Text] [Related]
11. Reduction of circulating secretory phospholipase A2 levels by anti-tumor necrosis factor chimeric monoclonal antibody in patients with severe Crohn's disease. Relation between tumor necrosis factor and secretory phospholipase A2 in healthy humans and in active Crohn's disease.
van Dullemen HM; Wolbink GJ; Wever PC; van der Poll T; Hack CE; Tytgat GN; van Deventer SJ
Scand J Gastroenterol; 1998 Oct; 33(10):1094-8. PubMed ID: 9829366
[TBL] [Abstract][Full Text] [Related]
12. Stimulation of group II phospholipase A2 mRNA expression and release in an immortalized astrocyte cell line (DITNC) by LPS, TNF alpha, and IL-1 beta. Interactive effects.
Tong W; Hu ZY; Sun GY
Mol Chem Neuropathol; 1995 May; 25(1):1-17. PubMed ID: 7546015
[TBL] [Abstract][Full Text] [Related]
13. Therapy with interleukin-2 induces the systemic release of phospholipase-A2.
Wolbink GJ; Schalkwijk C; Baars JW; Wagstaff J; van den Bosch H; Hack CE
Cancer Immunol Immunother; 1995 Nov; 41(5):287-92. PubMed ID: 8536274
[TBL] [Abstract][Full Text] [Related]
14. Downregulation of the proinflammatory cytokine response to endotoxin by pretreatment with the nontoxic lipid A analog SDZ MRL 953 in cancer patients.
Kiani A; Tschiersch A; Gaboriau E; Otto F; Seiz A; Knopf HP; Stütz P; Färber L; Haus U; Galanos C; Mertelsmann R; Engelhardt R
Blood; 1997 Aug; 90(4):1673-83. PubMed ID: 9269788
[TBL] [Abstract][Full Text] [Related]
15. Elevated plasma phospholipase A2 levels: correlation with the hemodynamic and pulmonary changes in gram-negative septic shock.
Vadas P
J Lab Clin Med; 1984 Dec; 104(6):873-81. PubMed ID: 6548766
[TBL] [Abstract][Full Text] [Related]
16. Induction of TNF-alpha and proinflammatory secretory phospholipase A2 by intravenous administration of CAMPATH-1H in patients with rheumatoid arthritis.
Pruzanski W; Urowitz MB; Grouix B; Vadas P
J Rheumatol; 1995 Oct; 22(10):1816-9. PubMed ID: 8991975
[TBL] [Abstract][Full Text] [Related]
17. Induction of circulating group II phospholipase A2 expression in adults with malaria.
Vadas P; Keystone J; Stefanski E; Scott K; Pruzanski W
Infect Immun; 1992 Sep; 60(9):3928-31. PubMed ID: 1500203
[TBL] [Abstract][Full Text] [Related]
18. Treatment of cancer patients with endotoxin induces release of endogenous cytokines.
Mackensen A; Galanos C; Engelhardt R
Pathobiology; 1991; 59(4):264-7. PubMed ID: 1715715
[TBL] [Abstract][Full Text] [Related]
19. Suppression of murine endotoxic shock by sPLA2 inhibitor, indoxam, through group IIA sPLA2-independent mechanisms.
Yokota Y; Hanasaki K; Ono T; Nakazato H; Kobayashi T; Arita H
Biochim Biophys Acta; 1999 May; 1438(2):213-22. PubMed ID: 10320804
[TBL] [Abstract][Full Text] [Related]
20. Increased serum phospholipase A2 activity in Malawian children with falciparum malaria.
Vadas P; Taylor TE; Chimsuku L; Goldring D; Stefanski E; Pruzanski W; Molyneux ME
Am J Trop Med Hyg; 1993 Oct; 49(4):455-9. PubMed ID: 8214274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
